Endurant Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-80,455	Closed	-$492K	–	48
2023 Q1	$492K	Buy	80,455 +9,800	+14%	+$67.6K	0.25%	42
2022 Q4	$451K	Buy	+70,655	New	+$552K	0.18%	48
2022 Q2	–	Sell	-60,720	Closed	-$1.01M	–	67
2022 Q1	$1.01M	Buy	60,720 +6,739	+12%	+$104K	0.31%	55
2021 Q4	$1.03M	Sell	53,981 -77,117	-59%	-$1.7M	0.28%	59
2021 Q3	$3.23M	Sell	131,098 -29,264	-18%	-$690K	0.98%	34
2021 Q2	$4.17M	Sell	160,362 -150,287	-48%	-$3.91M	1.15%	35
2021 Q1	$9.84M	Buy	310,649 +256,428	+473%	+$10.6M	2.67%	14
2020 Q4	$2.52M	Buy	+54,221	New	+$2.15M	0.91%	36
2020 Q2	–	Sell	-20,207	Closed	-$605K	–	66
2020 Q1	$605K	Sell	20,207 -148,339	-88%	-$3.93M	0.27%	42
2019 Q4	$4.67M	Buy	168,546 +82,477	+96%	+$1.88M	1.5%	22
2019 Q3	$1.57M	Sell	86,069 -87,169	-50%	-$1.93M	0.6%	32
2019 Q2	$4.25M	Buy	+173,238	New	+$2.61M	1.67%	26
2019 Q1	–	Sell	-318,185	Closed	-$2.82M	–	78
2018 Q4	$2.82M	Buy	318,185 +76,016	+31%	+$733K	1.49%	22
2018 Q3	$2.72M	Buy	+242,169	New	+$3.44M	1.21%	27